SCHEMBL7378447

SCHEMBL7378447

COc1ccc(NC(c2ccc(Cl)cc2CN2CCC[C@]2(C(N)=O)C(=O)OC(C)(C)C)C(F)F)cc1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 1/20 0.35
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
DDR1 Q08345 1/20 0.32
EP300 Q09472 4/20 0.32
CREBBP Q92793 4/20 0.32
MMP1 P03956 1/20 0.32
MMP9 P14780 1/20 0.32
MMP13 P45452 1/20 0.32
ADAM17 P78536 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7377904 0.90 MDM2 (0.35) MDM2ALDH1A1KDM4EMEN1GAA
SCHEMBL7379415 0.87 MAPT (0.32) MDM2ALDH1A1MEN1KMT2ADDR1
SCHEMBL7379279 0.75 CNR1 (0.35) MDM2ALDH1A1DDR1EP300CREBBP
SCHEMBL6925575 0.75 EGFR (0.45) MDM2ALDH1A1KDM4EEP300CREBBP
SCHEMBL6925078 0.72 ALDH1A1 (0.61) ALDH1A1KDM4EMEN1KMT2AL3MBTL1
SCHEMBL6920228 0.71 ALDH1A1 (0.49) MDM2ALDH1A1KDM4EMEN1GAA
SCHEMBL6920258 0.71 MEN1 (0.46) MDM2ALDH1A1KDM4EMEN1GAA
SCHEMBL6925573 0.65 KDM4E (0.43) MDM2ALDH1A1KDM4EMEN1GAA
SCHEMBL6925564 0.65 EGFR (0.45) MDM2ALDH1A1KDM4EDDR1EP300
SCHEMBL7379171 0.64 DRD2 (0.37) ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002050056-A1 BENZYLAMINE DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS MERCK & CO., INC. (US) 2002-06-27 WO disclosed